Status:
RECRUITING
Fluorescence Image Guided Foregut Surgery
Lead Sponsor:
IHU Strasbourg
Conditions:
Esophageal Cancer
Gastric Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A high number of resected lymph nodes is an independent prognostic factor for improved survival after esophagectomy or gastrectomy for cancer. The quality of the lymphadenectomy is operator-dependent,...
Detailed Description
In cancer surgery, an oncological resection involves the resection of the primary lesion but also of the loco-regional lymph nodes.In the large retrospective study of the Global Group of esophageal ca...
Eligibility Criteria
Inclusion
- Man or woman over 18 years old.
- Patient with resectable primitive esophageal or gastric cancer confirmed by biopsy without distant metastases
- Patient with no contraindications to anaesthesia and performance of esophageal and/or gastric surgery
- Patient able to receive and understand information related to the study and give written informed consent.
- Patient affiliated to the French social security system.
Exclusion
- Patient undergoing emergency surgery (hemorrhage, occlusion or perforation).
- Presence of distant metastasis
- Patient at risk of allergy to indocyanine green or to other fluorescent compounds
- Pregnant or lactating patient.
- Patient in exclusion period (determined by a previous or a current study).
- Patient under the protection of justice.
- Patient under guardianship or trusteeship.
- Patient deprived of liberty
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04734821
Start Date
April 1 2021
End Date
March 31 2026
Last Update
May 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Chirurgie Digestive et Endocrinienne, NHC
Strasbourg, France, 67000